A microbial consortium alters intestinal and antimicrobial resistance genes in individuals with recurrent infection.

Intestinal colonization with pathogens and antimicrobial-resistant organisms (AROs) is associated with increased risk of infection. Fecal microbiota transplant (FMT) has successfully been used to cure recurrent infection (rCDI) and to decolonize intestinal AROs. However, FMT has significant practical barriers to safe and broad implementation.